Image

Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)

Recruiting
18 - 39 years of age
Female
Phase N/A

Powered by AI

Overview

This is an observational epidemiologic multicentric study of follow-up a cohort for described the situation of patients with primary ovarian insufficiency in public population with respect to the age of apparition the primary ovarian insufficiency .

iPOI (Investigators in premature ovarian insufficiency): M. Guinot, B. Roca, J. Tomás, P. Escamilla, J. Hernández, P. Llaneza, N. Mendoza Ladrón de Guevara, B. Otero García, I. Ñiguez, A. Castro, L. Baquedano, P. Romero, S. Sánchez.

Eligibility

Inclusion criteria:

  • Women between 18 years and 39 years.
  • Primary ovarian insufficiency demonstrated with amenorrhea and levels of follicle stimulating hormone (FSH) over to 40 IU in two determinations measured with a difference of one moth.
  • Not present linguistic barriers ,shaw attitude towards collaboration ,be able to attend the study center for all follow-up visits.
  • Signed informed consent before inclusion in the study and after having been informed of the procedures performed in this study.

Exclusion criteria :

  • Women with secondary hormonal alteration that do no meet the diagnostic criteria of the disease.
  • Refusal to participate.
  • Withdrawal of informed consent.

Study details

Primary Ovarian Insufficiency

NCT02068976

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.